This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Guirakhoo, F.
Right arrow Articles by Monath, T. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Guirakhoo, F.
Right arrow Articles by Monath, T. P.

 Previous Article  |  Next Article 

Journal of Virology, August 2001, p. 7290-7304, Vol. 75, No. 16
0022-538X/01/$04.00+0   DOI: 10.1128/JVI.75.16.7290-7304.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.

Construction, Safety, and Immunogenicity in Nonhuman Primates of a Chimeric Yellow Fever-Dengue Virus Tetravalent Vaccine

F. Guirakhoo,1,* J. Arroyo,1 K. V. Pugachev,1 C. Miller,1 Z.-X. Zhang,1 R. Weltzin,1 K. Georgakopoulos,1 J. Catalan,1 S. Ocran,1 K. Soike,2 M. Ratterree,2 and T. P. Monath1

Acambis, Inc., Cambridge, Massachusetts 02139,1 and Tulane Regional Primate Research Center, Covington, Louisiana 704332

Received 13 March 2001/Accepted 25 May 2001

We previously reported construction of a chimeric yellow fever-dengue type 2 virus (YF/DEN2) and determined its safety and protective efficacy in rhesus monkeys (F. Guirakhoo et al., J. Virol. 74:5477-5485, 2000). In this paper, we describe construction of three additional YF/DEN chimeras using premembrane (prM) and envelope (E) genes of wild-type (WT) clinical isolates: DEN1 (strain PUO359, isolated in 1980 in Thailand), DEN3 (strain PaH881/88, isolated in 1988 in Thailand), and DEN4 (strain 1228, isolated in 1978 in Indonesia). These chimeric viruses (YF/DEN1, YF/DEN3, and YF/DEN4) replicated to ~7.5 log10 PFU/ml in Vero cells, were not neurovirulent in 3- to 4-week-old ICR mice inoculated by the intracerebral route, and were immunogenic in monkeys. All rhesus monkeys inoculated subcutaneously with one dose of these chimeric viruses (as monovalent or tetravalent formulation) developed viremia with magnitudes similar to that of the YF 17D vaccine strain (YF-VAX) but significantly lower than those of their parent WT viruses. Eight of nine monkeys inoculated with monovalent YF/DEN1 -3, or -4 vaccine and six of six monkeys inoculated with tetravalent YF/DEN1-4 vaccine seroconverted after a single dose. When monkeys were boosted with a tetravalent YF/DEN1-4 dose 6 months later, four of nine monkeys in the monovalent YF/DEN groups developed low levels of viremia, whereas no viremia was detected in any animals previously inoculated with either YF/DEN1-4 vaccine or WT DEN virus. An anamnestic response was observed in all monkeys after the second dose. No statistically significant difference in levels of neutralizing antibodies was observed between YF virus-immune and nonimmune monkeys which received the tetravalent YF/DEN1-4 vaccine or between tetravalent YF/DEN1-4-immune and nonimmune monkeys which received the YF-VAX. However, preimmune monkeys developed either no detectable viremia or a level of viremia lower than that in nonimmune controls. This is the first recombinant tetravalent dengue vaccine successfully evaluated in nonhuman primates.

* Corresponding author. Mailing address: Acambis, Inc., 38 Sidney St., Cambridge, MA 02139. Phone: (617) 494-1339. Fax: (617) 494-1741. E-mail: farshad.guirakhoo{at}acambis.com.

Journal of Virology, August 2001, p. 7290-7304, Vol. 75, No. 16
0022-538X/01/$04.00+0   DOI: 10.1128/JVI.75.16.7290-7304.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Johnson, B. W., Kosoy, O., Hunsperger, E., Beltran, M., Delorey, M., Guirakhoo, F., Monath, T. (2009). Evaluation of Chimeric Japanese Encephalitis and Dengue Viruses for Use in Diagnostic Plaque Reduction Neutralization Tests. CVI 16: 1052-1059 [Abstract] [Full Text]  
  • Lobigs, M., Larena, M., Alsharifi, M., Lee, E., Pavy, M. (2009). Live Chimeric and Inactivated Japanese Encephalitis Virus Vaccines Differ in Their Cross-Protective Values against Murray Valley Encephalitis Virus. J. Virol. 83: 2436-2445 [Abstract] [Full Text]  
  • Etemad, B., Batra, G., Raut, R., Dahiya, S., Khanam, S., Swaminathan, S., Khanna, N. (2008). An Envelope Domain III-based Chimeric Antigen Produced in Pichia pastoris Elicits Neutralizing Antibodies Against All Four Dengue Virus Serotypes. Am J Trop Med Hyg 79: 353-363 [Abstract] [Full Text]  
  • Yoshii, K., Goto, A., Kawakami, K., Kariwa, H., Takashima, I. (2008). Construction and application of chimeric virus-like particles of tick-borne encephalitis virus and mosquito-borne Japanese encephalitis virus. J. Gen. Virol. 89: 200-211 [Abstract] [Full Text]  
  • Shustov, A. V., Mason, P. W., Frolov, I. (2007). Production of Pseudoinfectious Yellow Fever Virus with a Two-Component Genome. J. Virol. 81: 11737-11748 [Abstract] [Full Text]  
  • White, L. J., Parsons, M. M., Whitmore, A. C., Williams, B. M., de Silva, A., Johnston, R. E. (2007). An Immunogenic and Protective Alphavirus Replicon Particle-Based Dengue Vaccine Overcomes Maternal Antibody Interference in Weanling Mice. J. Virol. 81: 10329-10339 [Abstract] [Full Text]  
  • DEAUVIEAU, F., SANCHEZ, V., BALAS, C., KENNEL, A., DE MONTFORT, A., LANG, J., GUY, B. (2007). INNATE IMMUNE RESPONSES IN HUMAN DENDRITIC CELLS UPON INFECTION BY CHIMERIC YELLOW-FEVER DENGUE VACCINE SEROTYPES 1-4. Am J Trop Med Hyg 76: 144-154 [Abstract] [Full Text]  
  • HIGGS, S., VANLANDINGHAM, D. L., KLINGLER, K. A., MCELROY, K. L., MCGEE, C. E., HARRINGTON, L., LANG, J., MONATH, T. P., GUIRAKHOO, F. (2006). GROWTH CHARACTERISTICS OF CHIMERIVAX-DEN VACCINE VIRUSES IN AEDES AEGYPTI AND AEDES ALBOPICTUS FROM THAILAND. Am J Trop Med Hyg 75: 986-993 [Abstract] [Full Text]  
  • Querec, T., Bennouna, S., Alkan, S., Laouar, Y., Gorden, K., Flavell, R., Akira, S., Ahmed, R., Pulendran, B. (2006). Yellow fever vaccine YF-17D activates multiple dendritic cell subsets via TLR2, 7, 8, and 9 to stimulate polyvalent immunity. JEM 203: 413-424 [Abstract] [Full Text]  
  • KHANAM, S., ETEMAD, B., KHANNA, N., SWAMINATHAN, S. (2006). INDUCTION OF NEUTRALIZING ANTIBODIES SPECIFIC TO DENGUE VIRUS SEROTYPES 2 AND 4 BY A BIVALENT ANTIGEN COMPOSED OF LINKED ENVELOPE DOMAINS III OF THESE TWO SEROTYPES. Am J Trop Med Hyg 74: 266-277 [Abstract] [Full Text]  
  • Blaney, J. E. Jr., Matro, J. M., Murphy, B. R., Whitehead, S. S. (2005). Recombinant, Live-Attenuated Tetravalent Dengue Virus Vaccine Formulations Induce a Balanced, Broad, and Protective Neutralizing Antibody Response against Each of the Four Serotypes in Rhesus Monkeys. J. Virol. 79: 5516-5528 [Abstract] [Full Text]  
  • BRANDLER, S., BROWN, N., ERMAK, T. H., MITCHELL, F., PARSONS, M., ZHANG, Z., LANG, J., MONATH, T. P., GUIRAKHOO, F. (2005). REPLICATION OF CHIMERIC YELLOW FEVER VIRUS-DENGUE SEROTYPE 1-4 VIRUS VACCINE STRAINS IN DENDRITIC AND HEPATIC CELLS. Am J Trop Med Hyg 72: 74-81 [Abstract] [Full Text]  
  • Pryor, M. J., Azzola, L., Wright, P. J., Davidson, A. D. (2004). Histidine 39 in the dengue virus type 2 M protein has an important role in virus assembly. J. Gen. Virol. 85: 3627-3636 [Abstract] [Full Text]  
  • BLANEY, J. E. JR., HANSON, C. T., FIRESTONE, C.-Y., HANLEY, K. A., MURPHY, B. R., WHITEHEAD, S. S. (2004). GENETICALLY MODIFIED, LIVE ATTENUATED DENGUE VIRUS TYPE 3 VACCINE CANDIDATES. Am J Trop Med Hyg 71: 811-821 [Abstract] [Full Text]  
  • PUGACHEV, K. V., GUIRAKHOO, F., MITCHELL, F., OCRAN, S. W., PARSONS, M., JOHNSON, B. W., KOSOY, O. L., LANCIOTTI, R. S., ROEHRIG, J. T., TRENT, D. W., MONATH, T. P. (2004). CONSTRUCTION OF YELLOW FEVER/ST. LOUIS ENCEPHALITIS CHIMERIC VIRUS AND THE USE OF CHIMERAS AS A DIAGNOSTIC TOOL. Am J Trop Med Hyg 71: 639-645 [Abstract] [Full Text]  
  • Guirakhoo, F., Zhang, Z., Myers, G., Johnson, B. W., Pugachev, K., Nichols, R., Brown, N., Levenbook, I., Draper, K., Cyrek, S., Lang, J., Fournier, C., Barrere, B., Delagrave, S., Monath, T. P. (2004). A Single Amino Acid Substitution in the Envelope Protein of Chimeric Yellow Fever-Dengue 1 Vaccine Virus Reduces Neurovirulence for Suckling Mice and Viremia/Viscerotropism for Monkeys. J. Virol. 78: 9998-10008 [Abstract] [Full Text]  
  • Mathenge, E. G. M., Parquet, M. d. C., Funakoshi, Y., Houhara, S., Wong, P. F., Ichinose, A., Hasebe, F., Inoue, S., Morita, K. (2004). Fusion PCR generated Japanese encephalitis virus/dengue 4 virus chimera exhibits lack of neuroinvasiveness, attenuated neurovirulence, and a dual-flavi immune response in mice. J. Gen. Virol. 85: 2503-2513 [Abstract] [Full Text]  
  • Charlier, N., Molenkamp, R., Leyssen, P., Paeshuyse, J., Drosten, C., Panning, M., De Clercq, E., Bredenbeek, P. J., Neyts, J. (2004). Exchanging the Yellow Fever Virus Envelope Proteins with Modoc Virus prM and E Proteins Results in a Chimeric Virus That Is Neuroinvasive in SCID Mice. J. Virol. 78: 7418-7426 [Abstract] [Full Text]  
  • Guirakhoo, F., Pugachev, K., Zhang, Z., Myers, G., Levenbook, I., Draper, K., Lang, J., Ocran, S., Mitchell, F., Parsons, M., Brown, N., Brandler, S., Fournier, C., Barrere, B., Rizvi, F., Travassos, A., Nichols, R., Trent, D., Monath, T. (2004). Safety and Efficacy of Chimeric Yellow Fever-Dengue Virus Tetravalent Vaccine Formulations in Nonhuman Primates. J. Virol. 78: 4761-4775 [Abstract] [Full Text]  
  • Pugachev, K. V., Guirakhoo, F., Ocran, S. W., Mitchell, F., Parsons, M., Penal, C., Girakhoo, S., Pougatcheva, S. O., Arroyo, J., Trent, D. W., Monath, T. P. (2004). High Fidelity of Yellow Fever Virus RNA Polymerase. J. Virol. 78: 1032-1038 [Abstract] [Full Text]  
  • JOHNSON, B. W., CHAMBERS, T. V., CRABTREE, M. B., GUIRAKHOO, F., MONATH, T. P., MILLER, B. R. (2004). ANALYSIS OF THE REPLICATION KINETICS OF THE CHIMERIVAXTM-DEN 1, 2, 3, 4 TETRAVALENT VIRUS MIXTURE IN AEDES AEGYPTI BY REAL-TIME REVERSE TRANSCRIPTASE-POLYMERASE CHAIN REACTION. Am J Trop Med Hyg 70: 89-97 [Abstract] [Full Text]  
  • Jaiswal, S., Khanna, N., Swaminathan, S. (2003). Replication-Defective Adenoviral Vaccine Vector for the Induction of Immune Responses to Dengue Virus Type 2. J. Virol. 77: 12907-12913 [Abstract] [Full Text]  
  • Huang, C. Y.-H., Butrapet, S., Tsuchiya, K. R., Bhamarapravati, N., Gubler, D. J., Kinney, R. M. (2003). Dengue 2 PDK-53 Virus as a Chimeric Carrier for Tetravalent Dengue Vaccine Development. J. Virol. 77: 11436-11447 [Abstract] [Full Text]  
  • Paessler, S., Fayzulin, R. Z., Anishchenko, M., Greene, I. P., Weaver, S. C., Frolov, I. (2003). Recombinant Sindbis/Venezuelan Equine Encephalitis Virus Is Highly Attenuated and Immunogenic. J. Virol. 77: 9278-9286 [Abstract] [Full Text]  
  • Chambers, T. J., Liang, Y., Droll, D. A., Schlesinger, J. J., Davidson, A. D., Wright, P. J., Jiang, X. (2003). Yellow Fever Virus/Dengue-2 Virus and Yellow Fever Virus/Dengue-4 Virus Chimeras: Biological Characterization, Immunogenicity, and Protection against Dengue Encephalitis in the Mouse Model. J. Virol. 77: 3655-3668 [Abstract] [Full Text]  
  • Molenkamp, R., Kooi, E. A., Lucassen, M. A., Greve, S., Thijssen, J. C. P., Spaan, W. J. M., Bredenbeek, P. J. (2002). Yellow Fever Virus Replicons as an Expression System for Hepatitis C Virus Structural Proteins. J. Virol. 77: 1644-1648 [Abstract] [Full Text]  
  • Whitehead, S. S., Falgout, B., Hanley, K. A., Blaney, J. E. Jr., Markoff, L., Murphy, B. R. (2002). A Live, Attenuated Dengue Virus Type 1 Vaccine Candidate with a 30-Nucleotide Deletion in the 3' Untranslated Region Is Highly Attenuated and Immunogenic in Monkeys. J. Virol. 77: 1653-1657 [Abstract] [Full Text]  
  • Markoff, L., Pang, X., Houng, H.-s., Falgout, B., Olsen, R., Jones, E., Polo, S. (2002). Derivation and Characterization of a Dengue Type 1 Host Range-Restricted Mutant Virus That Is Attenuated and Highly Immunogenic in Monkeys. J. Virol. 76: 3318-3328 [Abstract] [Full Text]  
  • Monath, T. P., Arroyo, J., Levenbook, I., Zhang, Z.-X., Catalan, J., Draper, K., Guirakhoo, F. (2002). Single Mutation in the Flavivirus Envelope Protein Hinge Region Increases Neurovirulence for Mice and Monkeys but Decreases Viscerotropism for Monkeys: Relevance to Development and Safety Testing of Live, Attenuated Vaccines. J. Virol. 76: 1932-1943 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»